Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Withdrawn 1Terminated 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphedema 1

Interventions

venetoclax 1futibatinib 1Tacrolimus 1Fulvestrant 1Cytarabine 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Enrolling by invitation × Tacrolimus × Clear all
NCT06306274 2024-12-02

Topical Tacrolimus for Breast Cancer-related Lymphedema

Odense University Hospital

Phase 2/3 Enrolling by invitation
80 enrolled

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡